Given that there are modifiable health and lifestyle factors that may reduce cognitive decline [26] and that APOE-specific interventions have been shown to be effective at mitigating cognitive decline in ɛ4 carriers [27], identifying these individuals at the earliest possible stage (i.e., SCD) is important. Here, APOE is linked to Schnyder corneal dystrophy.